CAMP4 Therapeutics

CAMP

3.6500.00% ( 0.000 )

Closed: Oct 28, 16:00:01 (EDT)

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: CAMP4 Therapeutics(CAMP) the Revenue is 1.779 M (+18.84%), Miss estimate;the EBIT is -13.38 M (-2.7%), Beat estimate;the EPS is -0.58 (+6.45%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.00B18.84%

0.00B26.25%

-0.00B7.41%

EBITExceed expectations

-0.01B2.70%

-0.01B3.07%

+0.00B0.37%

EPSMiss expectations

-0.586.45%

-0.211165.96%

-0.368959.51%

Upcoming earnings report - Q3 FY2026

Available dateNov 6, 2026

Estimate Revenue$1.931 M

Estimate EBIT-$14.36 M

Estimate EPS-$0.1864

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly